These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2890119

  • 1. Purification of a kappa-opioid receptor subtype from frog brain.
    Simon J, Benyhe S, Hepp J, Khan A, Borsodi A, Szücs M, Medzihradszky K, Wollemann M.
    Neuropeptides; 1987 Jul; 10(1):19-28. PubMed ID: 2890119
    [Abstract] [Full Text] [Related]

  • 2. Separation of kappa-opioid receptor subtype from frog brain.
    Simon J, Benyhe S, Borsodi A, Szücs M, Wollemann M.
    FEBS Lett; 1985 Apr 22; 183(2):395-7. PubMed ID: 2985433
    [Abstract] [Full Text] [Related]

  • 3. Method for isolation of kappa-opioid binding sites by dynorphin affinity chromatography.
    Simon J, Benyhe S, Hepp J, Varga E, Medzihradszky K, Borsodi A, Wollemann M.
    J Neurosci Res; 1990 Apr 22; 25(4):549-55. PubMed ID: 1972199
    [Abstract] [Full Text] [Related]

  • 4. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP.
    J Pharmacol Exp Ther; 1985 Jan 22; 232(1):144-8. PubMed ID: 2856939
    [Abstract] [Full Text] [Related]

  • 5. Opioid ligand binding sites in the spinal cord of the guinea-pig.
    Zarr GD, Werling LL, Brown SR, Cox BM.
    Neuropharmacology; 1986 May 22; 25(5):471-80. PubMed ID: 3016586
    [Abstract] [Full Text] [Related]

  • 6. [3H]dynorphin1-8 binding sites in frog (Rana esculenta) brain membranes.
    Benyhe S, Simon J, Borsodi A, Wollemann M, Barnard EA.
    Neuropeptides; 1994 May 22; 26(5):359-64. PubMed ID: 7915022
    [Abstract] [Full Text] [Related]

  • 7. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW, Liu-Chen LY.
    J Pharmacol Exp Ther; 1986 Nov 22; 239(2):351-7. PubMed ID: 3021954
    [Abstract] [Full Text] [Related]

  • 8. Differential ontogeny of multiple opioid receptors (mu, delta, and kappa).
    Spain JW, Roth BL, Coscia CJ.
    J Neurosci; 1985 Mar 22; 5(3):584-8. PubMed ID: 2983043
    [Abstract] [Full Text] [Related]

  • 9. Differential effect of stimulation strength in mouse vas deferens on inhibition of neuroeffector transmission by receptor type selective opioids.
    Ramme D, Illes P.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan 22; 332(1):57-61. PubMed ID: 2869418
    [Abstract] [Full Text] [Related]

  • 10. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B, Rajpara A, O'Connor LH, Cicero TJ.
    Life Sci; 1988 Jan 22; 42(23):2403-12. PubMed ID: 2836684
    [Abstract] [Full Text] [Related]

  • 11. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane.
    Fedynyshyn JP, Kwiat G, Lee NM.
    Eur J Pharmacol; 1989 Jan 02; 159(1):83-8. PubMed ID: 2540013
    [Abstract] [Full Text] [Related]

  • 12. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J, Sánchez-Blázquez P, Lee NM.
    J Pharmacol Exp Ther; 1984 Oct 02; 231(1):33-7. PubMed ID: 6092603
    [Abstract] [Full Text] [Related]

  • 13. Functional opioid receptor sites in human placentas.
    Belisle S, Petit A, Gallo-Payet N, Bellabarba D, Lehoux JG, Lemaire S.
    J Clin Endocrinol Metab; 1988 Feb 02; 66(2):283-9. PubMed ID: 2892853
    [Abstract] [Full Text] [Related]

  • 14. Affinities of some common opioid analgesics towards four binding sites in mouse brain.
    Neil A.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Nov 02; 328(1):24-9. PubMed ID: 6151117
    [Abstract] [Full Text] [Related]

  • 15. The occurrence of different kappa opioid receptors (K1 and K2) in frog (Rana esculenta) brain membranes.
    Benyhe S, Varga E, Borsodi A, Wollemann M.
    Acta Physiol Hung; 1990 Nov 02; 76(4):291-4. PubMed ID: 1966577
    [Abstract] [Full Text] [Related]

  • 16. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.
    Portoghese PS, Lipkowski AW, Takemori AE.
    Life Sci; 1987 Mar 30; 40(13):1287-92. PubMed ID: 2882399
    [Abstract] [Full Text] [Related]

  • 17. Temperature dependence of the binding of mu, delta and kappa agonists to the opiate receptors in guinea-pig brain.
    Borea PA, Bertelli GM, Gilli G.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):247-52. PubMed ID: 2836208
    [Abstract] [Full Text] [Related]

  • 18. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL, Zarr GD, Brown SR, Cox BM.
    J Pharmacol Exp Ther; 1985 Jun 09; 233(3):722-8. PubMed ID: 2989494
    [Abstract] [Full Text] [Related]

  • 19. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
    Takemori AE, Ho BY, Naeseth JS, Portoghese PS.
    J Pharmacol Exp Ther; 1988 Jul 09; 246(1):255-8. PubMed ID: 2839664
    [Abstract] [Full Text] [Related]

  • 20. Presynaptic opioid receptors modulating acetylcholine release in the hippocampus of the rabbit.
    Jackisch R, Geppert M, Brenner AS, Illes P.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb 09; 332(2):156-62. PubMed ID: 2871497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.